Biogeography of the Oral Microbiome

Clinical Trial Description

This study will collect samples from participants meeting the eligibility criteria over the span of 3 months. Samples will be collected from multiple locations within the oral cavity and metatranscriptomically analyzed. ;

Study Design

Related Conditions & MeSH terms

Oral Microbiome

See also
Status	Clinical Trial	Phase
Completed	`NCT03748017` - The Probiotic for Oral Health (PRO Health) Study	N/A
Active, not recruiting	`NCT04139538` - Microbiome and Immunogenity of Saliva During Orthodontic Therapy	N/A
Recruiting	`NCT04993846` - Pancreatic Cancer and Oral Microbiome
Completed	`NCT05270382` - Effect of Mouthwashes on Oral Wound Healing and Microbiome	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT03748017 - The Probiotic for Oral Health (PRO Health) Study

N/A

Active, not recruiting

NCT04139538 - Microbiome and Immunogenity of Saliva During Orthodontic Therapy

N/A

Recruiting

NCT04993846 - Pancreatic Cancer and Oral Microbiome

Completed

NCT05270382 - Effect of Mouthwashes on Oral Wound Healing and Microbiome

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT05672953
Study type	Observational
Source	Viome
Contact
Status	Completed
Phase
Start date	May 20, 2021
Completion date	August 10, 2021

Biogeography of the Oral Microbiome

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms